Litcius/Paper detail

Quantitative Microbial Risk Assessment for Airborne Transmission of SARS-CoV-2 via Breathing, Speaking, Singing, Coughing, and Sneezing

Jack Schijven, Lucie C. Vermeulen, Arno Swart, Adam Meijer, Erwin Duizer, Ana Maria de Roda Husman

2021Environmental Health Perspectives131 citationsDOIOpen Access PDF

Abstract

BACKGROUND: Evidence for indoor airborne transmission of SARS-CoV-2 is accumulating. OBJECTIVES: We assessed of the risk of illness due to airborne SARS-CoV-2 particles from breathing, speaking, singing, coughing, and sneezing in indoor environments. METHODS: CoV2, for exposure to SARS-CoV-2 particles in aerosol droplets was developed. Previously published data on droplets expelled by breathing, speaking, singing, coughing, and sneezing by an infected person were used as inputs. Scenarios encompassed virus concentration, exposure time, and ventilation. Newly collected data of virus RNA copies in mucus from patients are presented. RESULTS: RNA copies/mL, and after 2 h of exposure, in the high and "low" sneeze scenarios, the high cough scenario and the singing scenario, risks exceeded 0.01 and may become very high, whereas the low coughing scenario, the high and low speaking scenarios and the breathing scenario remained below 0.1. After 2 h of exposure, singing became the second highest risk scenario. One air exchange per hour reduced risk of illness by about a factor of 2. Six air exchanges per hour reduced risks of illness by a factor of 8-13 for the sneeze and cough scenarios and by a factor of 4-9 for the other scenarios. DISCUSSION: CoV2 is made available as interactive computational tool. https://doi.org/10.1289/EHP7886.

Topics & Concepts

MedicineVentilation (architecture)Airborne transmissionBreathingRisk factorTidal volumeCoronavirus disease 2019 (COVID-19)AerosolEnvironmental healthRespiratory systemAnesthesiaInternal medicineMeteorologyDiseasePhysicsInfectious disease (medical specialty)Infection Control and VentilationIndoor Air Quality and Microbial ExposureDental Research and COVID-19